EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 166 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $26 | +4.0% | 933 | 0.0% | 0.00% | – |
| Q4 2022 | $25 | -99.9% | 933 | 0.0% | 0.00% | – |
| Q3 2022 | $25,000 | -39.0% | 933 | 0.0% | 0.00% | – |
| Q2 2022 | $41,000 | +78.3% | 933 | +85.1% | 0.00% | – |
| Q1 2020 | $23,000 | -97.5% | 504 | -96.7% | 0.00% | -100.0% |
| Q4 2019 | $909,000 | +6.3% | 15,122 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $855,000 | +408.9% | 15,122 | +400.4% | 0.01% | +500.0% |
| Q2 2019 | $168,000 | -86.4% | 3,022 | -83.1% | 0.00% | -88.9% |
| Q3 2018 | $1,239,000 | – | 17,877 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 3,652,284 | $302,920,000 | 91.10% |
| Hudson Executive Capital LP | 1,901,200 | $157,686,000 | 21.62% |
| JW Asset Management, LLC | 525,755 | $43,606,000 | 9.08% |
| Cormorant Asset Management, LP | 200,000 | $16,588,000 | 2.41% |
| Park West Asset Management LLC | 488,128 | $40,485,000 | 2.36% |
| Opaleye Management Inc. | 50,000 | $4,147,000 | 2.06% |
| Ranger Investment Management | 283,954 | $23,551,000 | 1.71% |
| Pier Capital, LLC | 74,732 | $6,198,000 | 1.06% |
| Bellevue Group AG | 67,700 | $5,615,000 | 0.75% |
| Orbimed Advisors | 671,000 | $55,653,000 | 0.63% |